Health in Tunisia

1,082 indicators covering health for Tunisia.

IndicatorLatest Year10-yr change Rank
Low birth weight number 16.7 2020 up 4.4% 71st
Number of new hivaids infections who 700 2024 up 29.6% 83rd
Reported rabies deaths 2 2019 down 33.3% 39th
Number of current cigarette smokers, estimate 1.77 million 2030 down 1.7% 55th
Reported number of children receiving antiretroviral therapy 48 2025 up 140.0% 87th
Concentrations of fine particulate matter 23.31 2023 up 8.5% 73rd
Death rate road traffic injuries 16.5 2019 down 31.0% 80th
New or unknown treatment history cases: Pulmonary, bacteriologically 932 2023 down 7.1% 111th
Medical doctors not further defined 15,108 2023 up 7.1% 45th
Life satisfaction vs life expectancy 76.51 2023 up 2.5% 98th
Estimate of current cigarette smoking prevalence 17.9% 2030 down 11.8% 50th
Estimate of current cigarette smoking prevalence (%) 18.5% 2030 down 9.8% 52nd
Tb patients tested positive for hiv 16 2021 up 60.0% 112th
Number of children aged 6-59 months with anaemia 309.89 2019 up 22.4% 81st
Prevalence of anaemia in children aged 6-59 months 30.4% 2019 up 0.7% 86th
Number of deaths attributed to non-communicable diseases, by type of 10,246 2019 up 27.1% 85th
Hepatitis B surface antigen (HBsAg) prevalence 0.1% 2024 down 50.0% 101st
Mean hemoglobin level of children aged 6-59 months 116 2019 unchanged 102nd
Estimated number of MDR/RR-TB incident cases 76 2024 up 40.7% 102nd
Mortality caused by road traffic injury 16.5 per 100,000 population 2019 down 30.7% 80th
Mortality caused by road traffic injury, female 9.5 per 100,000 female population 2019 down 32.6% 71st
Mortality caused by road traffic injury, male 23.6 per 100,000 male population 2019 down 29.8% 89th
Countries with birth registration data that are at least 90 percent 1 2024 unchanged 2nd
Ipv vaccine coverage 96 2024 down 2.0% 70th
Deaths in armed conflicts by country, annual growth rate -100 % change on previous year 2017 unchanged 33rd
Deaths in armed conflicts by region, annual growth rate -100 % change on previous year 2017 unchanged 33rd
Tb patients living with hiv receiving art 16 2021 up 60.0% 100th
HIV-positive TB patients on ART (antiretroviral therapy) 100.0% 2023 unchanged 1st
Hospital beds 18.21 2023 up 0.7% 99th
Treatment success rate for patients treated for MDR-TB 60.0% 2021 down 20.0% 120th
New leprosy case detection rate per 1 000 000 population 0.161 2023 β€” 114th
Treatment success rate: HIV-positive TB cases 91 2019 down 9.0% 20th
Prevalence of wasting, weight for height 2.1% 2018 down 38.2% 78th
Polio vaccine: inactivated second or third-dose polio vaccine (IPVc) 97.0% 2025 β€” 29th
International Health Regulations core capacity scores, SPAR version 70 2025 β€” 49th
Prevalence of underweight, weight for age 1.6% 2018 down 51.5% 91st
Health statistics - Regions (for 'Developer API') β€” Crude mortality 3.39 Per 1 000 inhabitants 2015 down 31.7% 45th
Health status - Regions β€” Crude mortality rate 3.39 Per 1 000 inhabitants 2015 down 31.7% 45th
Leprosy registered prevalence rate per 1 000 000 population 0.161 2023 β€” 112th
Leprosy - Number of new leprosy cases among children 0 2023 β€” 69th
Leprosy - Number of cases registered for treatment 2 2023 β€” 109th
New leprosy child case detection rate (less than 15 years of age) per 0 2023 β€” 69th
Children (0-14) living with HIV 200 2024 unchanged 77th
Ipv1 number unvaccinated 6,717 2023 up 52.3% 100th
Children living with hiv 200 2024 unchanged 77th
Contraceptive prevalence, any method 54.0% 2023 down 13.6% 63rd
Children (ages 0-14) newly infected with HIV 100 2024 unchanged 51st
Number of reported cases of poliomyelitis by wild poliovirus 0 2023 β€” 3rd
Age-standardized prevalence of current tobacco use among persons aged 24.4% 2024 down 10.6% 47th
Number of children newly infected with hiv 100 2024 unchanged 51st
Share of children under fifteen years old with hiv 27.61 2024 down 5.1% 72nd
Number of female leprosy new cases 2 2023 β€” 83rd
National smoking ban: NUMBER OF PLACES SMOKE-FREE 0 2022 β€” 155th
Contraceptive prevalence, any modern method 48.4% 2023 down 4.9% 54th
Number of prevalent tuberculosis cases 4,600 2014 up 53.3% 100th
Number of new G2D leprosy cases 0 2023 β€” 86th
Leprosy - New leprosy cases with G2D rate per 1 000 000 population 0 2023 β€” 86th
Proportion of total government spending on essential services, health 4.5% 2012 down 23.8% 104th
Inflation-adjusted prices for most sold brand of cigarettes: Prices 4.31 2022 down 4.6% 126th
Taxes as a % of price: total tax 69.4% 2022 down 10.8% 60th